Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic Landscape and Emerging Therapies in Uveal Melanoma
Rino S. Seedor, Marlana Orloff, Takami Sato
Cancers (2021) Vol. 13, Iss. 21, pp. 5503-5503
Open Access | Times Cited: 24

Showing 24 citing articles:

GNAQ and GNA11 Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma
Paula Silva, Daniel Fernández‐Díaz, Manuel F. Bande, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3066-3066
Open Access | Times Cited: 56
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Yasaman Zohrab Beigi, Hossein Lanjanian, Reyhane Fayazi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 11
Genetics and RNA Regulation of Uveal Melanoma
Cristina Barbagallo, Michele Stella, Giuseppe Broggi, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 775-775
Open Access | Times Cited: 21
Darovasertib, a novel treatment for metastatic uveal melanoma
Lei Cao, Shuzhen Chen, Rainie Sun, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Liver metastasis in uveal melanoma — treatment options and clinical outcome
Snježana Kaštelan, Danijela Mrazovac Zimak, Mira Ivanković, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 2
Open Access | Times Cited: 20
Molecular Insights into IQSEC2 Disease
Nina S. Levy, Veronika Borisov, Orit Lache, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4984-4984
Open Access | Times Cited: 12
Genetic and Epigenetic Features of Uveal Melanoma—An Overview and Clinical Implications
Daria Pašalić, Tamara Nikuševa-Martić, Ankica Sekovanić, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12807-12807
Open Access | Times Cited: 11
How we treat patients with metastatic uveal melanoma
Erick Figueiredo Saldanha, Maria Flávia Marques Ribeiro, Ian Hirsch, et al.
ESMO Open (2025) Vol. 10, Iss. 4, pp. 104496-104496
Closed Access
Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma
Daniël P. de Bruyn, Natasha M. van Poppelen, Tom Brands, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 2, pp. 11-11
Open Access | Times Cited: 3
The Current State of Systemic Therapy of Metastatic Uveal Melanoma
Elias A. T. Koch, Markus V. Heppt, Carola Berking
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 5, pp. 691-700
Open Access | Times Cited: 3
Combination of Immune Checkpoint Inhibitors and Liver-Specific Therapies in Liver-Metastatic Uveal Melanoma: Can We Thus Overcome Its High Resistance?
Chiara L. Blomen, Julian Kött, Tabea I. Hartung, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6390-6390
Open Access | Times Cited: 15
Clinical Outcomes after International Referral of Uveal Melanoma Patients for Proton Therapy
Marina Marinkovic, Lennart J. Pors, Vincent van den Berg, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6241-6241
Open Access | Times Cited: 14
LINC01278 Induces Autophagy to Inhibit Tumour Progression by Suppressing the mTOR Signalling Pathway
Bo Liu, Xueting Yao, Chaoyang Zhang, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-22
Open Access | Times Cited: 5
Expression of GNAQ, BAP1, SF3B1, and EIF1AX Proteins in the Aqueous Humor of Eyes Affected by Uveal Melanoma
Giulia Midena, Raffaele Parrozzani, Luisa Frizziero, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 1, pp. 15-15
Open Access | Times Cited: 1
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
Elias A. T. Koch, Anne Petzold, Edgar Dippel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Reciprocal positive regulation between BRD4 and YAP in GNAQ-mutant uveal melanoma cells confers sensitivity to BET inhibitors
Guiming Zhang, Sisi Huang, Lin-Xuan Ye, et al.
Pharmacological Research (2022) Vol. 184, pp. 106464-106464
Closed Access | Times Cited: 6
KDELR3 Is a Prognostic Biomarker Related to the Immune Infiltration and Chemoresistance of Anticancer Drugs in Uveal Melanoma
Jingnan Zhang, Juan Zhang, Jing Guan, et al.
Disease Markers (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 5
Identification of Immune-Related lncRNAs for Predicting Prognosis and Immune Landscape Characteristics of Uveal Melanoma
Wei Chen, Liying Yan, Bo Long, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 4
The RNA N6-methyladenosine demethylase FTO regulates ATG5 to inhibit malignant progression of uveal melanoma
Ya-Ting Yang, Yusheng Zhong, Cheng Chi, et al.
Journal of Proteomics (2024) Vol. 309, pp. 105282-105282
Open Access
Immunoembolization for the Treatment of Uveal Melanoma Hepatic Metastases
Carin F. Gonsalves
Seminars in Interventional Radiology (2024) Vol. 41, Iss. 01, pp. 020-026
Closed Access
Case Report: GNAQ- and SF3B1 Mutations in an Aggressive Case of Relapsing Uveal Ring Melanoma
Michelle Prasuhn, Josephine Christin Freitag, Sabine Lüken, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
Development and Validation of a Hypoxia - Related Prognostic Signature for Uveal melanoma
Kunxia Lin, Zheng Mi, Nuo Xu
Research Square (Research Square) (2022)
Open Access
The construction of a hypoxia-based signature identified CA12 as a risk gene affecting uveal melanoma cell malignant phenotypes and immune checkpoint expression
Yan Yin, Wei Du, Fei Li
Frontiers in Oncology (2022) Vol. 12
Open Access
Metastatic Behavior of Uveal Melanoma: From Biology to Treatment
İrem Koç, Hayyam Kıratlı
Springer eBooks (2022), pp. 143-150
Closed Access
Page 1

Scroll to top